Influence of ethanol on the pharmacokinetic properties of Δ 9-tetrahydrocannabinol in oral fluid

Journal of Analytical Toxicology

Volumn 37, Issue 3, 2013, Pages 152-158

  Toennes, Stefan W ^a   Schneider, Kirsten ^a   Wunder, Cora ^a   Kauert, Gerold F ^a   Moeller, Manfred R ^b   Theunissen, Eef L ^c   Ramaekers, Johannes G ^c  

^a GOETHE UNIVERSITY   (Germany)

^b SAARLAND UNIVERSITY   (Germany)

^c MAASTRICHT UNIVERSITY   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

ALCOHOL; CANNABIS; TETRAHYDROCANNABINOL;

ADULT; ALCOHOL CONSUMPTION; ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; DRINKING; FEMALE; HUMAN; MALE; SENSITIVITY AND SPECIFICITY; SMOKING;

ADULT; ALCOHOL DRINKING; ALCOHOLIC BEVERAGES; AUTOMOBILE DRIVING; CRIME; CROSS-OVER STUDIES; DOUBLE-BLIND METHOD; DRUG INTERACTIONS; ETHANOL; FEMALE; GAS CHROMATOGRAPHY-MASS SPECTROMETRY; HUMANS; MALE; MARIJUANA ABUSE; MARIJUANA SMOKING; NETHERLANDS; PREDICTIVE VALUE OF TESTS; SALIVA; SENSITIVITY AND SPECIFICITY; SUBSTANCE ABUSE DETECTION; TETRAHYDROCANNABINOL; YOUNG ADULT;

EID: 84875238245     PISSN: 01464760     EISSN: 19452403     Source Type: Journal    
DOI: 10.1093/jat/bkt002     Document Type: Article

References (25)

1. Bosker, W.M., Huestis, M.A. (2009) Oral fluid testing for drugs of abuse. Clinical Chemistry, 55, 1910-1931.
2. Ravera, S., de Gier, J.J. (2008) Prevalence of Psychoactive Substances in the General Population: 6th Framework Programme, Deliverable 2.1.1. BASt. http://www.druid-project.eu/cln_031/nn_107548/Druid/ EN/deliverales-list/downloads/Deliverable_2_1_1,templateId=raw, property=publicationFile.pdf/Deliverable_2_ 1_1.pdf (accessed 2 June 2012).
3. Druid-Project Homepage (2007) BASt. www.druid-project.eu (accessed 2 June 2012).
4. Wille, S.M.R., Samyn, N., Ramírez-Fernańdez, M.D.M., de Boeck, G. (2010) Evaluation of on-site oral fluid screening using Drugwipe-5(+), RapidSTAT and Drug Test 5000 for the detection of drugs of abuse in drivers. Forensic Science International, 198, 2-6.
5. Toennes, S.W., Kauert, G.F., Steinmeyer, S., Moeller, M.R. (2005) Driving under the influence of drugs-Evaluation of analytical data of drugs in oral fluid, serum and urine, and correlation with impairment symptoms. Forensic Science International, 152, 149-155.
6. Blencowe, T., Pehrsson, A., Lillsunde, P., Vimpari, K., Houwing, S., Smink, B. et al. (2011) An analytical evaluation of eight on-site oral fluid drug screening devices using laboratory confirmation results from oral fluid. Forensic Science International, 208, 173-179.
7. Menkes, D.B., Howard, R.C., Spears, G.F., Cairns, E.R. (1991) Salivary THC following cannabis smoking correlates with subjective intoxication and heart rate. Psychopharmacology, 103, 277-279.
8. Niedbala, R.S., Kardos, K.W., Fritch, D.F., Kardos, S., Fries, T., Waga, J. et al. (2001) Detection of marijuana use by oral fluid and urine analysis following single-dose administration of smoked and oral marijuana. Journal of Analytical Toxicology, 25, 289-303.
9. Huestis, M.A., Cone, E.J. (2004) Relationship of Delta 9-tetrahydrocannabinol concentrations in oral fluid and plasma after controlled administration of smoked cannabis. Journal of Analytical Toxicology, 28, 394-399.
10. Kauert, G.F., Ramaekers, J.G., Schneider, E., Moeller, M.R., Toennes, S.W. (2007) Pharmacokinetic properties of delta9-tetrahydrocannabinol in serum and oral fluid. Journal of Analytical Toxicology, 31, 288-293.
11. Ramaekers, J.G., Theunissen, E.L., Brouwer, M., de Toennes, S.W., Moeller, M.R., Kauert, G. (2011) Tolerance and cross-tolerance to neurocognitive effects of THC and alcohol in heavy cannabis users. Psychopharmacology, 214, 391-401.
12. Toennes, S.W., Schneider, K., Kauert, G.F., Wunder, C., Moeller, M.R., Theunissen, E.L. et al. (2011) Influence of ethanol on cannabinoid pharmacokinetic parameters in chronic users. Analytical and Bioanalytical Chemistry, 400, 145-152.
13. Ramaekers, J.G., Kauert, G., van Ruitenbeek, P., Theunissen, E.L., Schneider, E., Moeller, M.R. (2006) High-potency marijuana impairs executive function and inhibitory motor control. Traffic Injury Prevention, 31, 2296-2303.
14. Bosker, W.M., Theunissen, E.L., Conen, S., Kuypers, K.P.C., Jeffery, W.K., Walls, H.C. et al. (2012) A placebo-controlled study to assess standardized field sobriety tests performance during alcohol and cannabis intoxication in heavy cannabis users and accuracy of point of collection testing devices for detecting THC in oral fluid. Psychopharmacology, 223, 439-446.
15. Kauert, G.F., Iwersen-Bergmann, S., Toennes, S.W. (2006) Assay of Delta9-tetrahydrocannabinol (THC) in oral fluid-evaluation of the OraSure oral specimen collection device. Journal of Analytical Toxicology, 30, 274-277.
16. Toennes, S.W., Ramaekers, J.G., Theunissen, E.L., Moeller, M.R., Kauert, G.F. (2010) Pharmacokinetic properties of delta9-tetrahydrocannabinol in oral fluid of occasional and chronic users. Journal of Analytical Toxicology, 34, 216-221.
17. Department of Health and Human Services, Substance Abuse and Mental Health Services Administration (SAMHSA) (2004) Proposed revisions to mandatory guidelines for federal workplace drug testing programs. Federal Register, 69, 19673-19731.
18. Hoffmann-La Roche, A.G. (ed.) (2003) Roche Lexikon Medizin: Das große deutschsprachige Lexikon der Medizin, 5th edition. Urban & Fischer, Stuttgart.
19. Toennes, S.W., Ramaekers, J.G., Theunissen, E.L., Moeller, M.R., Kauert, G.F. (2008) Comparison of cannabinoid pharmacokinetic properties in occasional and heavy users smoking a marijuana or placebo joint. Journal of Analytical Toxicology, 32, 470-477.
20. Wille, S.M.R., Raes, E., Lillsunde, P., Gunnar, T., Laloup, M., Samyn, N. et al. (2009) Relationship between oral fluid and blood concentrations of drugs of abuse in drivers suspected of driving under the influence of drugs. Therapeutic Drug Monitoring, 31, 511-519.
21. Blencowe, T., Pehrsson, A., Lillsunde, P. (2010) Analytical evaluation of oral fluid screening devices and preceding selection procedures: 6th Framework Programme, Deliverable 3.2.2. BASt. http://www. druid project.eu/cln_031/nn_107548/Druid/EN/deliverales-list/downloads/Deliverable_3_2_2,templateId=raw,property=publicationFile.pdf/Deliverable_3_2_2.pdf (accessed 2 June 2012).
22. Milman, G., Barnes, A.J., Schwope, D.M., Schwilke, E.W., Darwin, W.D., Goodwin, R.S. et al. (2010) Disposition of cannabinoids in oral fluid after controlled around-the-clock oral THC administration. Clinical Chemistry, 56, 1261-1269.
23. Lee, D., Schwope, D.M., Milman, G., Barnes, A.J., Gorelick, D.A., Huestis, M.A. (2012) Cannabinoid disposition in oral fluid after controlled smoked cannabis. Clinical Chemistry, 58, 748-756.
24. Toennes, S.W., Steinmeyer, S., Maurer, H.-J., Moeller, M.R., Kauert, G.F. (2005) Screening for drugs of abuse in oral fluid-Correlation of analysis results with serum in forensic cases. Journal of Analytical Toxicology, 29, 22-27.
25. Karschner, E.L., Schwilke, E.W., Lowe, R.H., Darwin, W.D., Herning, R.I., Cadet, J.L. et al. (2009) Implications of plasma Delta9-tetrahydrocannabinol, 11-hydroxy-THC, and 11-nor-9-carboxy-THC concentrations in chronic cannabis smokers. Journal of Analytical Toxicology, 33, 469-477.